Background Coronavirus-like particles (CoVLP) that are produced in plants and display the
prefusion spike glycoprotein of the original strain of severe acute respiratory syndrome …

Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being
deployed, but the global need greatly exceeds the supply, and different formulations might …

During the past few decades, increasing concern about environmental pollution has led to
many investigations on heavy metals and their distribution in the sea, air or biological …

Background Seasonal influenza remains a substantial public health threat despite the availability
of egg-derived and other vaccines. Plant-based manufacturing might address some of …

Ebola virus causes severe hemorrhagic fever in susceptible hosts. Currently, no licensed
vaccines or treatments are available; however, several experimental vaccines have been …

Background New influenza vaccines eliciting more effective protection are needed,
particularly for the elderly who paid a large and disproportional toll of hospitalization and dead …

Recent issues regarding efficacy of influenza vaccines have re-emphasized the need of
new approaches to face this major public health issue. In a phase 1–2 clinical trial, healthy …

Ebola virus (EBOV) is one of the most lethal filoviruses, with mortality rates of up to 90% in
humans. Previously, we demonstrated 100% and 50% survival of EBOV-infected …

Even though ferrets are one of the principal animal models for influenza pathogenesis, the
lack of suitable immunological reagents has so far limited their use in host response studies. …

Although antivirals are important tools to control severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, effective vaccines are essential to control the current …